180 Life Sciences Corp appointed Eric R. Van Lent as Chief Accounting Officer effective February 15, 2025, replacing Blair Jordan, who stepped down from the role on the same date; Van Lent will be paid $8,000 per month for his services. Additionally, the company issued 65,000 shares of restricted stock to each of its four non-executive directors, vesting in 2025.